American Bio Medica Corporation Share Price

Equities

ABMC

US0246001087

Medical Equipment, Supplies & Distribution

Delayed OTC Markets 10:44:04 17/05/2024 pm IST 5-day change 1st Jan Change
0.0001 USD -66.67% Intraday chart for American Bio Medica Corporation -66.67% 0.00%
Sales 2021 2.22M 185M Sales 2022 913K 76.01M Capitalization 265K 22.02M
Net income 2021 - 0 Net income 2022 -1M -83.25M EV / Sales 2021 1.47 x
Net Debt 2021 1.47M 122M Net Debt 2022 2.21M 184M EV / Sales 2022 2.71 x
P/E ratio 2021
-3.46 x
P/E ratio 2022
-0.19 x
Employees 20
Yield 2021 *
-
Yield 2022
-
Free-Float 77.98%
More Fundamentals * Assessed data
Dynamic Chart
American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
American Bio Medica Corporation Auditor Raises 'Going Concern' Doubt CI
American Bio Medica Corporation Announces Termination of Melissa A. Waterhouse as Principal Financial Officer CI
American Bio Medica Corporation Announces Termination of Melissa A. Waterhouse as Chief Executive Officer CI
Healgen Scientific LLC completed the acquisition of substantially all of the operating assets of American Bio Medica Corporation. CI
Healgen Scientific LLC agreed to acquire substantially all of the operating assets of American Bio Medica Corporation for $3 million. CI
American Bio Medica Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
American Bio Medica Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
American Bio Medica Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
American Bio Medica Corporation Auditor Raises 'Going Concern' Doubt CI
American Bio Medica Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
American Bio Medica Corporation announced that it has received $0.1 million in funding CI
Declaration of Voting Results by American Bio CI
John J. Moroney Engages in Discussions with American Bio Medica CI
More news
1 day-66.67%
1 week-66.67%
Current month-95.00%
1 month-66.67%
6 months-50.00%
More quotes
1 week
0.00
Extreme 0.0001
0.00
1 month
0.00
Extreme 0.0001
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.02
3 years
0.00
Extreme 0
0.10
5 years
0.00
Extreme 0
1.26
10 years
0.00
Extreme 0
1.26
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 01/97/01
Chief Tech/Sci/R&D Officer 48 01/06/01
Director/Board Member 81 12/08/12
Members of the board TitleAgeSince
Chief Executive Officer 54 01/97/01
Director/Board Member 81 12/08/12
Director/Board Member 55 05/18/05
More insiders
Date Price Change Volume
17/24/17 0.0001 -66.67% 14,335

Delayed Quote OTC Markets, May 17, 2024 at 10:44 pm IST

More quotes
American Bio Medica Corporation is engaged in the manufacturing and distribution of lateral flow immunoassay tests, primarily for the immediate detection of drugs in urine and oral fluid. The Company also distributes a number of other products related to the immediate detection of drugs and alcohol. It manufactures a number of products that detect the presence or absence of drugs in urine. It manufactures the various urine drug testing product lines, including The Rapid Drug Screen (RDS), RDS InCup, Rapid TOX, Rapid TOX Cup and Private Label Products. RDS is a patented rapid drug test that detects the presence or absence of 2-10 drugs simultaneously in a single urine specimen. RDS InCup is a drug-testing cup that detects the presence or absence of 1-12 drugs in a urine specimen. Its OralStat is a drug test for the detection of drugs in oral fluids. Its Respiratory Syncytial Virus (RSV) test does detect RSV in both children under the age of six, as well as adults over the age of 60.
More about the company